ARNA

Arena Pharmaceuticals, Inc. Press Releases

$4.04
*  
0.07
1.76%
Get ARNA Alerts
*Delayed - data as of Jul. 31, 2015 10:09 ET  -  Find a broker to begin trading ARNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARNA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Arena Pharmaceuticals to Host Second Quarter 2015 Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 5
7/30/2015 8:00:00 AM - PR Newswire
▼-1.22 % Price Change since this news event. The Volume Ratio is 1.26.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals Initiates a Phase 2 Clinical Trial of APD334, its S1P1 Receptor Modulator for Autoimmune Diseases
7/29/2015 8:00:00 AM - PR Newswire
▼-5.61 % Price Change since this news event. The Volume Ratio is 1.12.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




The Challenge of Improving - BrokerBank Securities
7/16/2015 9:00:00 AM - PR Newswire
▼-16.36 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals Announces the Departure of Chief Financial Officer
6/16/2015 4:30:00 PM - PR Newswire
▼-7.55 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Lorcaserin HCl Data to be Presented at American Diabetes Association's 75th Scientific Sessions
6/4/2015 1:30:00 PM - PR Newswire
▼-4.49 % Price Change since this news event. The Volume Ratio is 1.32.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference
5/26/2015 8:00:00 AM - PR Newswire
▼-3.35 % Price Change since this news event. The Volume Ratio is 0.77.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Eisai and Arena Pharmaceuticals Announce Presentation of Lorcaserin HCl Data at Upcoming Medical Meetings
5/14/2015 8:00:00 AM - PR Newswire
▼-6.05 % Price Change since this news event. The Volume Ratio is 0.86.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2015 Financial Results
5/11/2015 4:07:00 PM - PR Newswire
▼-6.05 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Arena Pharmaceuticals and Roivant Sciences Enter into Collaboration for Nelotanserin, a Novel Inverse Agonist of the 5-HT2A Receptor
5/11/2015 4:01:00 PM - PR Newswire
▼-2.65 % Price Change since this news event. The Volume Ratio is 1.28.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day